Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.67 USD | -0.27% | -8.25% | -29.83% |
05-15 | Eagle Pharmaceuticals, Inc. Enters into a Third Amendment to Third Amended and Restated Credit Agreement | CI |
05-06 | North American Morning Briefing : Stock Futures -2- | DJ |
Sales 2021 | 172M 236M | Sales 2022 | 317M 435M | Capitalization | 380M 523M |
---|---|---|---|---|---|
Net income 2021 | -8M -10.99M | Net income 2022 | 35M 48.07M | EV / Sales 2021 | 3.44 x |
Net cash position 2021 | 67.84M 93.17M | Net Debt 2022 | 10.19M 13.99M | EV / Sales 2022 | 1.23 x |
P/E ratio 2021 |
-77
x | P/E ratio 2022 |
10.7
x | Employees | 134 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 65.14% |
Latest transcript on Eagle Pharmaceuticals, Inc.
1 day | -0.27% | ||
1 week | -8.25% | ||
Current month | +5.76% | ||
1 month | -19.16% | ||
3 months | -35.95% | ||
6 months | -29.96% | ||
Current year | -29.83% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Graves
CEO | Chief Executive Officer | 61 | 13-10-31 |
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 07-02-28 |
Ryan Debski
CMP | Compliance Officer | - | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 07-02-28 |
Jennifer Simpson
BRD | Director/Board Member | 55 | 19-08-27 |
Richard Edlin
BRD | Director/Board Member | 63 | 17-03-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.54% | 28 M€ | -2.97% | ||
0.25% | 26 M€ | -4.10% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 3.67 | -0.27% | 88,522 |
24-06-11 | 3.68 | +3.37% | 92,104 |
24-06-10 | 3.56 | -4.04% | 293,775 |
24-06-07 | 3.71 | -0.54% | 50,011 |
24-06-06 | 3.73 | -6.75% | 51,672 |
Delayed Quote Nasdaq, June 12, 2024 at 04:00 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-29.83% | 47.66M | |
+20.51% | 82.93B | |
+13.33% | 9.15B | |
+48.35% | 4.65B | |
-20.52% | 4.58B | |
+7.99% | 4.07B | |
+9.03% | 2.24B | |
-25.72% | 2.21B | |
+12.16% | 2.03B | |
-41.98% | 1.82B |
- Stock Market
- Equities
- EGRX Stock